In clinical trials, approximately 7% of patients experienced an adverse drug reaction associated with the use of Emadine; however, less than 1% of these patients discontinued therapy due to these adverse drug reactions.
Kliinilistes katsetes ilmnes ligikaudu 7% - l patsientidest Emadine’ i kasutamisega seotud kõrvaltoimeid; kuigi ravi katkestas selletõttu vähem kui 1% patsientidest.